Ушбу ишга иқтибос қилган ишлар

4 та иш

Иш: Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes

1. Multidrug-resistant tuberculosis in Uzbekistan: results of a nationwide survey, 2010 to 2011

   Dilrabo Ulmasova, G Uzakova, M N Tillyashayhov +17

   МақолаTuberculosis Research and EpidemiologyEurosurveillance201315 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.163910

2. Effectiveness and safety of standardised shorter regimens for multidrug-resistant tuberculosis: individual patient data and aggregate data meta-analyses

   Faiz Ahmad Khan, M Salim, Philipp du Cros +9

   Шарҳ мақолаTuberculosis Research and EpidemiologyEuropean Respiratory Journal20174 иқтибос

   ABIABI:AkademIndex/openalex/2017.review-article.000004

3. Identification of patients who could benefit from bedaquiline or delamanid: a multisite MDR-TB cohort study

   M. Bonnet, Mathieu Bastard, Philipp du Cros +9

   МақолаTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease20150 иқтибос

   ABIABI:AkademIndex/openalex/2015.article.000040

4. Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study

   Mathieu Bastard, Elisabeth Sánchez-Padilla, Philipp du Cros +12

   МақолаTuberculosis Research and EpidemiologyPLoS ONE20180 иқтибос

   ABIABI:AkademIndex/openalex/2018.article.000060